Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China.
Vet Comp Oncol. 2023 Sep;21(3):520-532. doi: 10.1111/vco.12915. Epub 2023 Jun 6.
Spontaneous canine mammary carcinomas (CMCs) have been widely considered a good research model for human breast cancers, which brings much attention to CMCs. In recent years, the oncolytic effect of Newcastle disease virus (NDV) on cancer cells has been widely studied, but its effect on CMCs is still unclear. This study aims to investigate the oncolytic effect of NDV LaSota strain on canine mammary carcinoma cell line (CMT-U27) in vivo and in vitro. The in vitro cytotoxicity and immunocytochemistry experiments showed that NDV selectively replicated in CMT-U27 cells, and inhibited cell proliferation and migration but not in MDCK cells. KEGG analysis of transcriptome sequencing indicated the importance of the TNFα and NF-κB signalling pathways in the anti-tumour effect of NDV. Subsequently, the significantly increased expression of TNFα, p65, phospho-p65, caspase-8, caspase-3 and cleaved-PARP proteins in the NDV group suggested that NDV induced CMT-U27 cells apoptosis by activating the caspase-8/caspase-3 pathway and the TNFα/NF-κB signalling pathway. Nude mice tumour-bearing experiments showed that NDV could significantly decrease the growth rate of CMC in vivo. In conclusion, our study demonstrates the effective oncolytic effects of NDV on CMT-U27 cells in vivo and in vitro, and suggests NDV as a promising candidate for oncolytic therapy.
自发性犬乳腺肿瘤(CMCs)一直被广泛认为是人类乳腺癌的良好研究模型,因此引起了广泛关注。近年来,新城疫病毒(NDV)对癌细胞的溶瘤作用已得到广泛研究,但对 CMCs 的作用尚不清楚。本研究旨在探讨 NDV LaSota 株在体内和体外对犬乳腺癌细胞系(CMT-U27)的溶瘤作用。体外细胞毒性和免疫细胞化学实验表明,NDV 选择性复制于 CMT-U27 细胞,抑制细胞增殖和迁移,但不复制于 MDCK 细胞。转录组测序的 KEGG 分析表明 TNFα 和 NF-κB 信号通路在 NDV 的抗肿瘤作用中很重要。随后,NDV 组 TNFα、p65、磷酸化 p65、caspase-8、caspase-3 和 cleaved-PARP 蛋白的表达显著增加,表明 NDV 通过激活 caspase-8/caspase-3 途径和 TNFα/NF-κB 信号通路诱导 CMT-U27 细胞凋亡。裸鼠荷瘤实验表明,NDV 能显著降低 CMC 在体内的生长速度。综上所述,本研究表明 NDV 对 CMT-U27 细胞具有有效的体内和体外溶瘤作用,提示 NDV 是一种很有前途的溶瘤治疗候选药物。